CAPS Rating

drneuro (56.81)

Results 1 - 20 of 43 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
24/10/2012 CPST.US 3 out of 5 Outperform 5Y $0.98 $1.03 (+8.50%) +5.20% +16.62% -11.42
16/05/2011 NBG.US 2 out of 5 Outperform 5Y $6.85 $1.22 (-8.27%) -82.19% +23.77% -105.96
17/06/2008 CZZ.US 3 out of 5 Outperform 3Y $10.87 $20.69 (-0.72%) +90.38% +25.20% +65.17
02/10/2006 17/06/2008 IMAX.US 4 out of 5 Outperform 5Y $4.91 $27.64 (-0.36%) +462.93% +31.42% +431.52
25/04/2008 HNP.US 2 out of 5 Outperform 3Y $26.88 $41.85 (-0.62%) +55.67% +22.97% +32.70
24/04/2008 JMBA.US 3 out of 5 Outperform 1Y $2.48 $3.02 (-2.58%) +21.77% +25.09% -3.31
28/03/2008 CRNT.US 4 out of 5 Outperform 5Y $9.78 $4.09 (+1.74%) -58.18% +29.36% -87.54
18/03/2008 MTENY.US 5 out of 5 Outperform 5Y $4.81 $0.72 (-10.00%) -85.04% +30.71% -115.74
18/03/2008 TLK.US 5 out of 5 Outperform 5Y $34.25 $49.75 (+1.24%) +45.26% +30.67% +14.60
18/03/2008 MYTAY.US 4 out of 5 Outperform 5Y $13.93 $8.14 (+3.43%) -41.54% +30.67% -72.21
17/03/2008 PETS.US 4 out of 5 Outperform 5Y $9.21 $13.22 (+1.15%) +43.52% +36.11% +7.40
11/02/2008 PDFS.US 5 out of 5 Outperform 1Y $5.96 $17.78 (-1.93%) +198.32% +29.43% +168.89
30/01/2008 MWA.US 4 out of 5 Outperform 5Y $7.70 $7.40 (-0.54%) -3.95% +27.07% -31.02
29/01/2008 GEX.US 2 out of 5 Outperform 5Y $43.24 $15.38 (+0.85%) -64.43% +26.58% -91.01
29/01/2008 GMK.US 4 out of 5 Outperform 5Y $11.12 $19.08 (-0.93%) +71.58% +26.58% +45.00
29/01/2008 TCM.US 2 out of 5 Outperform 5Y $8.42 $4.44 (0%) -47.27% +26.58% -73.85
29/01/2008 SBS.US 5 out of 5 Outperform 5Y $5.87 $13.59 (-1.66%) +131.66% +26.58% +105.08
29/01/2008 EXEL.US 5 out of 5 Outperform 5Y $7.36 $4.74 (-0.63%) -35.60% +26.58% -62.18
29/01/2008 BWLD.US 4 out of 5 Outperform 5Y $23.15 $94.53 (-0.72%) +308.34% +26.58% +281.75
29/01/2008 IMMR.US 3 out of 5 Outperform 3Y $9.04 $14.49 (+1.83%) +60.29% +26.58% +33.70
Results 1 - 20 of 43 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.